Cargando…
Effects of the AMPA Antagonist ZK 200775 on Visual Function: A Randomized Controlled Trial
BACKGROUND: ZK 200775 is an antagonist at the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and had earned attention as a possible neuroprotective agent in cerebral ischemia. Probands receiving the agent within phase I trials reported on an alteration of visual perception. In this...
Autores principales: | Bergholz, Richard, Staks, Thomas, Rüther, Klaus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920815/ https://www.ncbi.nlm.nih.gov/pubmed/20711429 http://dx.doi.org/10.1371/journal.pone.0012111 |
Ejemplares similares
-
Enabling Blockchain Services for IoE with Zk-Rollups
por: Lavaur, Thomas, et al.
Publicado: (2022) -
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
por: Stupp, R., et al.
Publicado: (2011) -
Potential inhibitory effects of compounds ZK-PI-5 and ZK-PI-9 on trehalose and chitin metabolism in Spodoptera frugiperda (J. E. Smith)
por: Zhong, Fan, et al.
Publicado: (2023) -
Modulation of suicidal erythrocyte cation channels by an AMPA antagonist
por: Föller, Michael, et al.
Publicado: (2009) -
Synthesis of Binderless ZK-4 Zeolite Microspheres at High Temperature
por: Fawaz, Elyssa G., et al.
Publicado: (2018)